TWO · 6610.TWO
TWi Biotechnology, Inc.
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
Loading market information…
TWO · 6926.TWO · TWD
Stock price
Quote as of Oct 30, 2026, 06:27 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Shine-On BioMedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
NT$54.00-NT$1.70 (-3.05%)
Sinew Pharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.47% below the high.
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
NT$45.75+NT$0.55 (+1.22%)
Sagittarius Life Science Corp’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
NT$29.00-NT$0.75 (-2.52%)
Apex Biotechnology Corp.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
NT$32.00-NT$0.60 (-1.84%)
Energenesis Biomedical CO.,LTD.’s quoted price sits in the lower half of its reported 52-week range, 46.4% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
NT$28.50-NT$1.60 (-5.32%)
3D Global Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
